GURU.Markets stock price, segment price, and overall market index valuation
The company's share price BioHarvest Sciences
Shares of BioHarvest, a company producing dietary supplements using biotechnology, reflect speculative interest in its unique platform. The price trajectory depends on the commercial success of its products and news about scientific research.
Share prices of companies in the market segment - Pharma other
BioHarvest Sciences has developed a "biofarming" technology that allows plant cells to be grown in bioreactors to produce useful compounds without growing the plant itself. We classify it under "Pharmaceuticals (Other)" due to its innovative approach. The chart below shows how investors view the prospects of this unique biotech.
Broad Market Index - GURU.Markets
BioHarvest Sciences is a biotechnology company that has developed a "biofarming" technology that allows plant cells to be grown in bioreactors to produce useful compounds. As a component of the GURU.Markets index, it represents the biotechnology sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
BHST - Daily change in the company's share price BioHarvest Sciences
BioHarvest Sciences' daily volatility reflects its extreme sensitivity to news in the biotech sector. Change_co for this company is a measure of speculative interest. This metric is important for analyzing risks in the emerging technologies sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma other
The biotech sector in which BioHarvest Sciences operates is highly dynamic. This chart reflects the industry's average volatility. It serves as a benchmark for assessing how sensitive BioHarvest's plant-based ingredients business is to overall trends.
Daily change in the price of a broad market stock, index - GURU.Markets
BioHarvest Sciences has developed a technology for growing plant cells in bioreactors to produce useful compounds. It is a unique company at the intersection of agritech and biotech. Its innovative model creates its own dynamics, which contribute to the overall picture of market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization BioHarvest Sciences
BioHarvest Sciences' year-to-date performance is a story of the commercialization of its unique biopharming technology. Its 12-month market cap reflects investors' belief that its method of growing plant cells in bioreactors could become a breakthrough platform for producing both dietary supplements (for example, from grapes) and cannabinoids.
Annual dynamics of market capitalization of the market segment - Pharma other
BioHarvest, a biotech company, is developing a unique technology for growing plant cells for the production of nutraceuticals. Its performance relative to the sector will demonstrate the extent of investor confidence in its innovative platform and its ability to commercialize its products in the growing health food market.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
BioHarvest Sciences is traded over-the-counter (OTC), which carries significant risks. As a dietary supplement producer, its stock performance depends not on the economy but on its marketing success and scientific evidence supporting its products' effectiveness. This chart represents a speculative story in the consumer health space.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization BioHarvest Sciences
BioHarvest Sciences focuses on producing nutrients from plant cells. The company's medium-term stock price reflects its operational success: news of production scaling, expansion into new markets, or sales growth for key products like VINIA can cause significant changes in its market valuation from month to month.
Monthly dynamics of market capitalization of the market segment - Pharma other
This chart reflects the dynamics of the biotech sector. For BioHarvest, with its unique plant cell culture platform, it's the backdrop. Its movements demonstrate how consumer trends toward natural products and scientific breakthroughs are influencing the entire industry.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
BioHarvest Sciences has developed a "biofarming" technology that allows plant cells to be grown in bioreactors to produce valuable compounds without growing the plant itself. A full-market chart helps assess how BioHarvest shares, as a venture bet on a technological breakthrough, can exhibit volatility unrelated to overall sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization BioHarvest Sciences
BioHarvest Sciences is a biotechnology company that has developed a "biofarming" technology that allows plant cells to be grown in bioreactors to produce useful compounds. Its weekly stock price is volatile and depends on the commercialization of its products.
Weekly dynamics of market capitalization of the market segment - Pharma other
BioHarvest Sciences has developed a technology for growing plant cells in bioreactors to produce useful substances. This innovative approach straddles the intersection of biotech and agritech. The chart below shows how expectations for this unique technology are impacting stock performance, distinguishing it from the traditional pharmaceutical sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
BioHarvest is a biotech company with innovative technology. The chart shows how expectations for this unique technology influence the stock's performance, distinguishing it from the market and creating its own investment profile, unrelated to the economy.
Market capitalization of the company, segment and market as a whole
BHST - Market capitalization of the company BioHarvest Sciences
BioHarvest Sciences' market capitalization is a speculative bet on its unique "bio-farming" technology, which allows plant cells to be grown in bioreactors. Its volatile price chart reflects investors' perceptions of its potential to produce nutraceuticals and cannabinoids without the need to grow the plants themselves.
BHST - Share of the company's market capitalization BioHarvest Sciences within the market segment - Pharma other
BioHarvest Sciences has developed a unique "biopharming" technology that allows plant cells to be grown in bioreactors to produce valuable compounds. Its market share currently reflects only potential. The graph is a venture bet that this technology will transform the production of food supplements and other products.
Market capitalization of the market segment - Pharma other
Here's a chart showing the biotech sector's market capitalization. BioHarvest Sciences is a unique company that grows plant cells in bioreactors to produce useful compounds. Its technology, compared to the market, is a bet on the possibility of obtaining valuable ingredients without having to grow entire plants.
Market capitalization of all companies included in a broad market index - GURU.Markets
BioHarvest Sciences has developed a biofarm technology that grows plant cells in bioreactors to produce useful compounds. Its capitalization is a bet on this platform. The graph below shows the growing importance of sustainable production technologies in the economy.
Book value capitalization of the company, segment and market as a whole
BHST - Book value capitalization of the company BioHarvest Sciences
BioHarvest's book value is derived from its unique biotech platform, Bio-Plant CELLicitation™, which enables the cultivation of plant cells in bioreactors to produce valuable phytochemicals. This chart tells the story of a company investing in scaling this unique "plant factory."
BHST - Share of the company's book capitalization BioHarvest Sciences within the market segment - Pharma other
BioHarvest Sciences has developed a technology for growing plant cells in bioreactors. The chart shows its share of real assets. These include its unique bioreactors and plant, which provide the physical basis for producing useful substances without growing entire plants.
Market segment balance sheet capitalization - Pharma other
BioHarvest Sciences, a biotech company, is a capital-intensive business due to its need to own bioreactors. The chart below illustrates the scale of the entire pharmaceutical sector, providing a backdrop for assessing its unique manufacturing base.
Book value of all companies included in the broad market index - GURU.Markets
BioHarvest Sciences has developed a technology for growing plant cells in bioreactors to produce active ingredients. The company's assets include its R&D and production facilities. Its stake in BCap_All provides the material basis for an innovative and sustainable method for producing valuable substances.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - BioHarvest Sciences
BioHarvest Sciences is a biotechnology company. Its high premium to its assets is a bet on its unique "biofarming" technology, which allows plant cells to be grown in bioreactors to produce useful compounds.
Market to book capitalization ratio in a market segment - Pharma other
BioHarvest Sciences has developed a technology for growing plant cells in bioreactors to produce valuable compounds. The company's value lies in its "biofarming" platform. The chart shows the premium investors are paying for the potential of this unique and sustainable technology.
Market to book capitalization ratio for the market as a whole
BioHarvest Sciences has developed a technology for growing plant cells in bioreactors to produce nutrients without growing the plant itself. This is innovative biotechnology. This chart shows the premium the market is willing to pay for breakthrough and sustainable production technologies over the cost of physical assets.
Debts of the company, segment and market as a whole
BHST - Company debts BioHarvest Sciences
BioHarvest Sciences, a biotech company with a unique plant cell culture platform, is using capital to commercialize its products. Its debt strategy may focus on building bioreactors, marketing nutraceuticals, and conducting research for pharmaceutical applications, all of which require significant investment.
Market segment debts - Pharma other
BioHarvest Sciences has developed a "biopharming" technology that allows plant cells to be grown in bioreactors to produce valuable compounds. This innovative approach straddles the intersection of biotech and agritech. This chart shows how the company is funding the scaling of its unique technology for commercial production.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio BioHarvest Sciences
BioHarvest Sciences has developed a technology for growing plant cells in bioreactors to produce useful compounds. Scaling up such production requires investment. This chart shows the company's use of debt capital to build its production facilities, which is an indicator of the risks involved in the commercialization phase.
Market segment debt to market segment book capitalization - Pharma other
BioHarvest Sciences has developed a biofarming technology that allows plant cells to be grown to produce beneficial compounds without growing the plant itself. The chart shows debt trends in their sector, helping to assess how the company is financing the commercialization of its unique and sustainable technology in the dietary supplements and nutraceuticals market.
Debt to book value of all companies in the market
BioHarvest Sciences has developed a "biopharming" technology that allows plant cells to be grown to produce useful compounds without growing the plant itself. This is an innovative technology that requires investment. This chart helps assess the company's stage. Is it a shareholder-funded startup, or is it already generating cash flow sufficient to raise debt?
P/E of the company, segment and market as a whole
P/E - BioHarvest Sciences
BioHarvest Sciences has developed a "biofarming" technology that allows plant cells to be grown to produce beneficial compounds without growing the plant itself. This chart shows investor expectations for this unique platform. The valuation is a bet on the commercialization of its technology in the food and wellness industries.
P/E of the market segment - Pharma other
This industry chart for biotech companies serves as a benchmark for BioHarvest Sciences. It reflects the overall sentiment in the sector. Comparisons with it help understand how the market views BioHarvest's unique technology for cultivating plant cells to produce biologically active compounds, which can be used in both dietary supplements and pharmaceuticals.
P/E of the market as a whole
BioHarvest Sciences has developed a biofarm technology that grows plant cells in bioreactors to produce beneficial compounds (such as antioxidants). This graph of investor interest in biotechnology and clean products shows whether they believe in the commercial potential of this innovative production platform.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company BioHarvest Sciences
BioHarvest Sciences has developed a biofarming technology that enables plant cells to be grown in bioreactors to produce active ingredients for dietary supplements and pharmaceuticals. This graph reflects the expectations for its unique platform. The valuation depends on the commercialization of its products and the potential of the technology to produce rare and valuable compounds.
%20P%2FE%20BioHarvest%20Sciences&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-BioHarvest-Sciences&v=1772642052988 "Chart of the company's future (projected) P/E BioHarvest Sciences")
Future (projected) P/E of the market segment - Pharma other
BioHarvest Sciences has developed a biofarming technology that allows plant cells to be grown in bioreactors to produce valuable phytochemicals. This chart reflects investor expectations for the company's profitability relative to the sector. It allows one to assess the market's confidence in its nutraceutical and cannabinoid production platform.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772642053005 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
BioHarvest Sciences has developed a "bio-farming" technology that allows plant cells to be grown in bioreactors to produce useful compounds. For an innovative company like BHST, this market sentiment graph is important. Their success depends on market acceptance of their new technology, and investor optimism facilitates raising capital for scaling up production.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772642053014 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit BioHarvest Sciences
BioHarvest Sciences has developed a unique "bio-farming" technology that allows plant cells to be grown in bioreactors to produce beneficial compounds without growing the plant itself. This chart shows the company's financial performance as it commercializes this innovative technology.
Profit of companies in the market segment - Pharma other
BioHarvest Sciences has developed a "biopharming" technology that allows plant cells to be grown in bioreactors to produce valuable compounds. This graph shows the profitability of the pharmaceutical sector. For BHST, this reflects its interest in new, sustainable methods for producing natural ingredients for dietary supplements and pharmaceuticals.
Overall market profit
BioHarvest Sciences has developed a unique "bio-farming" technology that allows plant cells to be grown in bioreactors to extract valuable phytochemicals (such as antioxidants from grapes). This is an innovative approach to producing ingredients for dietary supplements and cosmetics. The company's growth depends on the commercialization of this technology.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company BioHarvest Sciences
BioHarvest Sciences has developed a unique biotech platform for growing plant cells in bioreactors to produce active ingredients. The revenue projections presented here reflect expectations for the commercialization of its products, such as grape polyphenols, in the dietary supplement market.
%20profit%20of%20the%20company%20BioHarvest%20Sciences&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-BioHarvest-Sciences&v=1772642053175 "Graph of future (projected) profit of the company BioHarvest Sciences")
Future (predicted) profit of companies in the market segment - Pharma other
BioHarvest Sciences uses biofarming technology to grow plant cells and extract useful compounds from them without the need to grow entire plants. The profit forecast for this sector depends on the commercial success of this innovative platform. This chart reflects analysts' confidence in the potential of new biotechnologies in pharmaceuticals and nutraceuticals.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772642053206 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
BioHarvest Sciences has developed a "biofarming" technology that allows plant cells to be grown in bioreactors to produce useful compounds. The company's growth depends on the commercialization of this innovative platform. The market profit forecasts shown here reflect the overall investor appetite for new green technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772642053214 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - BioHarvest Sciences
BioHarvest Sciences has developed a "biofarming" technology that allows plant cells to be grown in bioreactors to produce valuable compounds. This chart shows a speculative valuation. Investors are betting on the potential of its platform for producing dietary supplements and, eventually, pharmaceutical ingredients.
P/S market segment - Pharma other
BioHarvest Sciences has developed a unique biotech platform that enables plant cell growth in bioreactors to produce valuable compounds without the need to grow the plants themselves. This chart shows the average revenue estimate in the biotech sector, helping to understand how investors view BioHarvest's innovative and sustainable technology.
P/S of the market as a whole
BioHarvest Sciences is a biotech company that has developed a unique platform for growing plant cells in bioreactors to produce health-promoting compounds without the need to grow the plant itself. This chart provides a general market backdrop for assessing investor sentiment toward innovative biotech and nutraceutical companies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company BioHarvest Sciences
BioHarvest Sciences has developed a biofarming technology that allows plant cells to be grown in bioreactors to produce beneficial compounds. This chart shows how investors estimate the company's future revenue. It reflects the potential of this technology in the dietary supplement and nutraceutical industries.
%20P%2FS%20BioHarvest%20Sciences&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-BioHarvest-Sciences&v=1772642053330 "The graph of the company's future (projected) P/S BioHarvest Sciences")
Future (projected) P/S of the market segment - Pharma other
BioHarvest Sciences has developed a unique bio-farming platform that enables the cultivation of plant cells in bioreactors to produce valuable phytochemicals. This chart reflects investors' confidence in its innovative technology and its potential for the nutraceutical and cannabinoid markets.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772642053352 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
BioHarvest Sciences is developing a technology for growing plant cells to produce bioactive compounds without the need to grow the entire plant. Their success depends on the commercialization of this technology. This market optimism is important. It ensures an influx of capital into innovative biotech platforms that have the potential to transform entire industries.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772642053371 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales BioHarvest Sciences
BioHarvest Sciences has developed a unique "biofarming" technology that allows plant cells to be grown in bioreactors to produce valuable active ingredients. This chart shows revenue from sales of products based on this technology, such as dietary supplements. Revenue growth reflects the commercialization of its innovative platform.
Sales of companies in the market segment - Pharma other
BioHarvest Sciences has developed a unique "bio-farming" technology that allows plant cells to be grown in bioreactors and extracted from them beneficial health compounds without growing the plant itself. Their first product is VINIA, a red grape-based product. Their revenue stream is generated by sales of these innovative nutraceuticals.
Overall market sales
BioHarvest Sciences is a biotechnology company that has developed a unique BioFarming platform that enables the cultivation of plant cells in bioreactors to produce beneficial compounds without the need to grow entire plants. This total revenue chart reflects the growing demand for natural and sustainable ingredients in the food and pharmaceutical industries.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company BioHarvest Sciences
BioHarvest Sciences has developed a "biopharming" technology that allows plant cells to be grown in bioreactors to produce beneficial compounds (such as antioxidants) without the need to grow whole plants. This timeline reflects the expected commercialization of this unique technology.
%20sales%20of%20the%20company%20BioHarvest%20Sciences&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-BioHarvest-Sciences&v=1772642053497 "Schedule of future (projected) sales of the company BioHarvest Sciences")
Future (projected) sales of companies in the market segment - Pharma other
BioHarvest Sciences has developed a unique "bio-farming" technology that allows plant cells to be grown in bioreactors to produce beneficial compounds. This chart shows forecasts for the nutraceutical and cannabinoid market. It reflects the potential of innovative technologies for producing pure and standardized plant ingredients.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772642053550 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
BioHarvest Sciences, a biotechnology company, sees this chart as a reflection of the consumer trend toward natural and healthy products. Rising economic forecasts are allowing consumers to spend more on their well-being. BioHarvest's technology enables the production of valuable plant components without growing the plants themselves.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772642053567 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality BioHarvest Sciences
BioHarvest Sciences has developed a technology for growing plant cells in bioreactors to produce active ingredients for dietary supplements and pharmaceuticals. Profitability depends on scaling up this unique technology. This chart shows how successfully the company is converting its scientific innovations into a commercially viable and profitable product.
Market segment marginality - Pharma other
BioHarvest Sciences has developed a "bio-farming" technology that allows plant cells to be grown in bioreactors to produce useful compounds. This metric reflects the commercial potential of its platform. Increased operational efficiency will drive demand for its eco-friendly ingredients.
Market marginality as a whole
BioHarvest Sciences is a biotechnology company with a unique platform for growing plant cells to produce valuable compounds. It is an early-stage company. This gross profitability chart does not reflect venture risks or the potential of the technology, which has yet to prove its commercial viability.
Employees in the company, segment and market as a whole
Number of employees in the company BioHarvest Sciences
BioHarvest Sciences has developed a unique biotech platform that enables plant cells to be grown in bioreactors to produce valuable compounds without having to grow the plant itself. This graphic shows a team of scientists using this technology to produce dietary supplements and, potentially, pharmaceutical ingredients.
Share of the company's employees BioHarvest Sciences within the market segment - Pharma other
BioHarvest Sciences has developed a unique "biofarming" technology that allows plant cells to be grown in bioreactors to produce useful compounds. This innovative technology requires a team of biologists and engineers. This graph illustrates its potential to transform the dietary supplement and pharmaceutical industries by harnessing unique talent.
Number of employees in the market segment - Pharma other
BioHarvest Sciences has developed a biofarming technology that allows plant cells to be grown in bioreactors to produce beneficial compounds (such as antioxidants) without the need to grow entire plants. This graphic shows the team of scientists who are changing the approach to producing natural ingredients for the food and cosmetics industries.
Number of employees in the market as a whole
BioHarvest Sciences Inc. has developed biofarming technology that enables the cultivation of plant cells to produce active ingredients for dietary supplements and pharmaceuticals. The overall employment dynamics shown here are impacting consumer spending. Rising incomes allow people to spend more on health and wellness products, creating a market for BioHarvest's innovative products.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company BioHarvest Sciences (BHST)
BioHarvest Sciences develops a technology for growing plant cells in bioreactors to produce beneficial substances. This chart represents a valuation of this unique biotechnology. The high market capitalization per employee indicates the market sees enormous potential in their platform, which could revolutionize the production of dietary supplements and pharmaceutical ingredients.
%20of%20the%20company%20BioHarvest%20Sciences%20(BHST)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-BioHarvest-Sciences-BHST&v=1772642053869 "Chart of market capitalization per employee (in thousands of dollars) of the company BioHarvest Sciences (BHST)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
BioHarvest Sciences has developed a plant cell culture technology for producing active ingredients for dietary supplements and pharmaceuticals. It's an innovative business at the intersection of biotech and agritech. This chart shows how the market values its unique platform and growth potential per employee.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772642053903 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
BioHarvest Sciences has developed a "bio-farming" technology that allows plant cells to be grown in bioreactors to produce valuable phytochemicals. This metric reflects the potential of its unique platform and demonstrates how the market perceives its ability to produce active ingredients without the need to grow entire plants.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772642053935 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company BioHarvest Sciences (BHST)
BioHarvest Sciences is a company with a unique "biofarming" technology that allows them to grow plant cells (such as grapes) in bioreactors to produce polyphenols. This chart shows how they are commercializing this technology. The key benefit lies in the ability to produce valuable ingredients without the need to grow entire plants.
%20Chart%20BioHarvest%20Sciences%20(BHST)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-BioHarvest-Sciences-BHST&v=1772642053971 "Company Profit Per Employee (in thousands of dollars) Chart BioHarvest Sciences (BHST)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
BioHarvest Sciences (BHST) is a biotechnology company that has developed a "biofarming" platform that allows plant cells to be grown in bioreactors to produce valuable compounds (such as polyphenols from grapes). This chart represents an industry benchmark. It reflects how effectively BioHarvest is scaling its unique technology to produce dietary supplements and, potentially, cannabinoids.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772642054002 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
BioHarvest Sciences is a biotech company that has developed a "biofarming" platform. They grow plant cells in bioreactors to produce desired compounds (for example, resveratrol from grapes) without growing the plant itself. This involves R&D and production. This graph shows how their team can scale this unique technology and commercialize its products.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772642054050 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee BioHarvest Sciences (BHST)
BioHarvest Sciences has developed a biofarming technology that allows plant cells to be grown in bioreactors to produce valuable compounds. This chart shows the commercialization of the innovative platform. The increase in revenue per employee reflects increased sales of its first product, VINIA (based on grapes), and the potential for other products.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-BioHarvest-Sciences-BHST&v=1772642054072 "Sales chart per company employee BioHarvest Sciences (BHST)")
Sales per employee in the market segment - Pharma other
BioHarvest Sciences (BHST) uses biofarming technology (growing plant cells) to produce nutraceuticals (for example, from grapes). It's a niche B2C and B2B business. This chart shows how effective their unique production and R&D model is in generating revenue per employee.
Sales per employee for the market as a whole
BioHarvest Sciences is a biotech company with a unique "bio-farm." They grow plant cells in bioreactors to create nutraceuticals (food supplements) and, in the future, cannabis compounds. This chart shows how their team of scientists and manufacturers is monetizing this innovative technology.
Short shares by company, segment and market as a whole
Shares shorted by company BioHarvest Sciences (BHST)
BioHarvest (BHST) is a biotech company using biofarming technology (growing plant cells in bioreactors) to produce nutraceuticals (such as grapes) and cannabinoids. This chart shows bearish bets. Bears may doubt the commercial viability of this technology or the real demand for their expensive dietary supplements.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-BioHarvest-Sciences-BHST&v=1772642054206 "Short Shares Chart for the Company BioHarvest Sciences (BHST)")
Shares shorted by market segment - Pharma other
BioHarvest (BHST) is a biotech company using biofarming technology to grow plant cells and produce active ingredients (for example, from grapes). This chart illustrates the general skepticism in the biotech sector, reflecting investor doubts about the commercial viability of this technology.
Shares shorted by the overall market
BioHarvest Sciences is working on "bio-farming"—the cultivation of valuable plant compounds. This is a speculative R&D story. When this indicator of general pessimism rises, investors immediately "flee risk." They are not willing to fund science; they want profit. Speculative biotech stocks like BHST are the first to sell off in the general wave of panic.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator BioHarvest Sciences (BHST)
BioHarvest Sciences is a company using biopharming technology to grow plant cells (for example, grape polyphenols) in bioreactors. This is a speculative R&D bet. This chart measures the level of hype. It shows when euphoria (overbought) or doubt (oversold) reaches its peak.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-BioHarvest-Sciences-BHST&v=1772642054406 "RSI 14 indicator chart for the company's stock BioHarvest Sciences (BHST)")
RSI 14 Market Segment - Pharma other
BioHarvest Sciences is a biotech company with a unique "biofarming" platform. They grow plant cells in bioreactors to produce valuable compounds (for example, antioxidants from grapes). This chart reflects the overall sentiment in the biotech sector and helps assess how the market views this speculative industry.
RSI 14 for the overall market
BioHarvest (BHST) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BHST (BioHarvest Sciences)
BioHarvest (BHST) is a biotechnology company using biofarming technology (growing plant cells in bioreactors) to produce nutraceuticals (VINIA) and cannabinoids. This chart shows the average price target, reflecting analysts' belief in this technology and its commercial potential.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BHST-BioHarvest-Sciences&v=1772642054502 "A chart showing analyst consensus forecasts for the expected stock price. BHST (BioHarvest Sciences)")
The difference between the consensus estimate and the actual stock price BHST (BioHarvest Sciences)
BioHarvest Sciences is a biotech company with a unique "bio-farming" platform. It grows plant cells (such as grapes) in bioreactors to create nutraceuticals. This chart shows how much the current stock price differs from the "fair" value predicted by analysts. It reflects their faith in this technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BHST-BioHarvest-Sciences&v=1772642054511 "A chart showing the difference between the consensus forecast and the actual stock price. BHST (BioHarvest Sciences)")
Analyst consensus forecast for stock prices by market segment - Pharma other
BioHarvest Sciences is a biotechnology company that has developed "biofarming"—a technology for growing plant cells (such as grapes) in bioreactors to produce polyphenols. This chart shows general expectations for the pharmaceutical sector. It reflects experts' confidence in the nutraceuticals and dietary supplements market.
Analysts' consensus forecast for the overall market share price
BioHarvest Sciences is a biotech company with a unique "bio-farming" platform. They grow valuable plant components (such as antioxidants) in bioreactors. This chart shows overall market sentiment. For BioHarvest, a "science" startup, it's important to understand how risk appetite (sentiment) influences funding for their innovative technology. (349)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index BioHarvest Sciences
BioHarvest Sciences is a biotech company with a unique bio-farm: they grow plant cells (such as grapes) in industrial-scale bioreactors to produce valuable active ingredients (antioxidants) without having to grow the plants themselves. This chart is an assessment of their unique platform. It reflects their commercial launch in the dietary supplement segment and their confidence in their R&D potential.
AKIMA Market Segment Index - Pharma other
BioHarvest Sciences develops biofarming technology, which enables the cultivation of plant cells in bioreactors to produce desired compounds (for example, from grapes). This chart shows the average index for the pharmaceutical sector. It helps investors assess how BioHarvest's innovative platform compares to the industry average.
The AKIM Index for the overall market
BioHarvest Sciences is a biotech company that grows plant cells (grapes, olives) in bioreactors to create superfoods. This chart, which reflects the market average, is just a backdrop. It helps assess how this innovative ingredient production technology compares to overall macroeconomic and healthy lifestyle trends.
